Categories

行业新闻

Siemens Enters Digital Pathology Market with Proscia’s Concentriq Dx Platform

经过Labmedica Internationalstaff writers
2022年3月23日

Image: Concentriq Dx digital pathology platform (Photo courtesy of Proscia)

随着长期以来威胁着围绕物理空间中病理学家和显微镜的传统实验室模型的系统挑战,对数字病理的需求激增了,在大流行和大流行时代已经加剧了。由于大流行驱动的转向偏远工作,使病理学家人群,活检量增加和行业整合产生的越来越大。现在,实验室正在迅速寻求现代化的病理操作,但是旧软件系统缺乏必要的企业范围内的功能,从而阻止了实验室实现真正的数字化。


In line with this trend, Siemens Healthineers (Erlangen, Germany) and Proscia (Philadelphia, PA, USA) have entered into a multi-year OEM agreement under which Siemens will expand its Enterprise Imaging offering towards the global digital pathology market using Proscia’s Concentriq Dx platform. With Proscia’s Concentriq Dx platform, Siemens is entering the digital pathology market to satiate the rampant demand and expand its Enterprise Imaging offering with industry-leading technology to realize the full value of digital pathology operations. The agreement with Proscia enables Siemens to expand into one of the few remaining areas of healthcare that has just started to experience the full benefits of digitization.


Proscia的Censuniq是一个单一可扩展的平台,使实验室网络能够统一病理运营并消除地理孤岛,以实现真正连接和协作的全球实践。该平台位于实验室的重心,将多样化的硬件和软件生态系统连接到单个解决方案中。Censureq以病理学家为中心的设计是由病理学家开发的,可以提供一种自然,反应迅速的界面,支持咨询和第二意见的实时协作,并使数字图像观看尽可能顺畅。现在,该平台的未来设计设计已准备好用于病理学的计算驱动的未来,其集成层能够支持AI应用程序的插件采用。


Siemens’ Syngo Carbon Enterprise Imaging Solution offers a wide range of possibilities with image interpretation, reporting, AI implementation, data management, archiving and migration, including unique access to innovation platforms through seamless integration. Proscia’s Concentriq Dx in combination with Syngo Carbon offers a best-of-breed solution for digitizing pathology operations at scale alongside diagnostic radiology imaging for healthcare enterprises. By entering the rapidly growing digital pathology market with Concentriq, Siemens is expanding its position as one of the industry leaders in healthcare with solutions covering the entire clinical pathway, providing a full spectrum of enterprise services across digital, data, and AI.


Siemens Healthineers Imaging Software及IT负责人Christian ZAPF说:“医疗保健的快速数字转型强调了数据在重塑临床医生和研究人员的理解,诊断和抗击疾病方面的价值。”“The traditional practice of pathology is on the verge of the biggest transformation the field has seen since the introduction of light microscopy, and we’re excited to accelerate pathology’s digital transformation and pioneer breakthroughs with a strong partner complementing our core strength in enterprise reading and reporting resulting in higher efficiency and improved patient outcomes.”


“Our partnership with Siemens Healthineers represents a seminal moment for Proscia and a monumental leap for digital pathology on a global scale,” said David West, CEO of Proscia. “We’re honored to work together with the worldwide leader in medical imaging to accelerate pathology’s digital transformation, improve the quality of care with more precise and personalized diagnoses, and ensure improved patient outcomes.”


相关链接:
西门子卫生师
proscia



E-mail Print
FaceBook 推特 Google+ 链接

西门子卫生师- Laboratory Diagnostics

为医疗行业提供高级实验室诊断解决方案新万博manbetx官网
更多信息

有关西门子卫生师的更多文章 - 实验室诊断

2021年12月2日
Siemens Partners with Biotech Company Freenome to Develop Blood Test for Early Breast Cancer Detection
西门子卫生师(Erlangen, Germany) and Freenome (South San Francisco, CA, USA) have entered into a collaboration in multiomics and radiomic breast cancer diagnostics to identify suitable markers for early breast cancer detection through blood to augment existing imaging technologies.
Read More
2021年2月5日
Siemens and Sysmex Extend Agreement to Provide One of the Largest Portfolios of Hemostasis Testing Systems and Reagents
西门子卫生师(德国埃尔兰根)和Sysmex Corporation(日本科比)为广泛的止血产品组合(包括多年扩展)续签了其长期存在的全球供应,分销,销售和服务协议。
Read More

Additional news

2022年6月27日
Robot-Assisted Surgical Devices Market Driven by Increased Demand for Patient-Specific Surgeries
鉴于生活方式疾病的发生率不断增长和对负担得起的医疗保健的需求,使用机器人设备的有效手术会导致治疗成本下降,并推动全球机器人辅助手术器械(RASD)市场的增长。
Read More
2022年6月24日
Fujirebio Acquires ADx NeuroSciences to Speed Development of Neurodegenerative Diseases Diagnostic Tests
Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction of customary closing conditions.
Read More
23 Jun 2022
Hospital Microbiology Testing Market Driven by Increasing Prevalence of Chronic Diseases
Rising medical expenditure as well as the presence of well-established modern healthcare infrastructure in various developed as well as developing regions is fueling the growth of the global hospital microbiology testing market.
Read More
22 Jun 2022
到2031年,全球微创手术(MIS)市场将超过3250亿美元
全球MIS市场预计到2031年将超过3250亿美元,这是由于患者对MIS与开放手术相比,手术机器人的持续创新以及其他错误相关技术的不断进步的认识越来越多。。
Read More
2022年6月21日
Medix Biochemica获取IVD原材料生产商Bioresource Technology
Medix Biochemica(芬兰ESPOO)已收购了Bioresource Technology(BRT,Weston,FL,USA)的100%股票,以扩大其基本矩阵能力,并进一步增强其在美国市场的本地业务。
Read More
2022年6月21日
全球床头测试市场见证重症监护的前景
在过去的几年中,护理点或使用点的诊断(也称为床头测试)在分析测试中的突出性提高了,因为它提供了临床相关的信息而无需专门的实验室。
Read More
2022年6月20日
Global Sepsis Diagnostics Market Driven by Rising Hospital-Acquired Illnesses
在2022 - 2028年期间,全球败血症诊断市场预计将以8.3%的复合年增长率增长,到2028年,由于医院获得的疾病数量的增加以及迅速增长的分子诊断市场,到2028年将达到8.8亿美元。尽管自动诊断工具的高成本可能会阻碍市场的增长。
Read More
2022年6月14日
BD Partners with Mayo Clinic Platform for Access to World's Largest Collection of Clinical Data
Becton,Dickinson and Company(BD,美国新泽西州富兰克林湖)与Mayo Clinic Platform(美国明尼苏达州罗切斯特)进行了合作,以访问Mayo Clinic Platform_discover的DE鉴定的患者数据。
Read More
2022年6月14日
Quidel Partners with Global Lyme Alliance, Leads in Lyme Disease Testing
Quidel Corporation(美国加利福尼亚州圣地亚哥)与全球莱姆联盟(美国康涅狄格州斯坦福大学)联手,提高了莱姆病宣传月(5月)及以后的莱姆病识别期间围绕莱姆病的公众意识。
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. |条款和条件